Previous studies indicated that miR-138 may have an effect on tumor metastasis by targeting SOX4 and Hif1a in ovarian cancer, MMP2/MMP9 in cholangiocarcinoma cells and FAK in hela cells [12,22,23]. Here, MMP9 is linked to ovarian cancer.